adenosine monophosphate has been researched along with Diabetic Nephropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, SK; Boehm, M; Borzilleri, KA; Brown, JA; Calabrese, M; Cameron, KO; Caspers, NL; Cokorinos, E; Conn, EL; Dowling, MS; Edmonds, DJ; Eng, H; Fernando, DP; Frisbie, R; Hepworth, D; Kalgutkar, AS; Kung, DW; Kurumbail, RG; Landro, J; Mao, Y; Miller, R; Rajamohan, F; Reyes, AR; Rose, CR; Ryder, T; Salatto, CT; Shavnya, A; Smith, AC; Tu, M; Ward, J; Withka, JM; Wolford, AC; Xiao, J | 1 |
| Feng, Y; Hu, W; Liu, J; Tan, B; Tong, Y; Wang, X; Xu, H; Yuan, M | 1 |
| Packer, M | 1 |
| Hong, X; Li, L; Qian, K; Sun, Y; Xue, Y; Zhao, Y; Zhou, Y | 1 |
| Escudero, C; Fuentealba, V; Gajardo, C; Pastor-Anglada, M; Quezada, C; Roa, H; San Martin, R; Sobrevia, L; Troncoso, E; Yáñez, A | 1 |
| Corongiu, F; Rosso, G | 1 |
1 review(s) available for adenosine monophosphate and Diabetic Nephropathies
| Article | Year |
|---|---|
Interplay of adenosine monophosphate-activated protein kinase/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: A novel conceptual framework.
Topics: Adenosine Monophosphate; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Humans; Kidney; Pharmaceutical Preparations; Protein Kinases; Sirtuin 1; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
5 other study(ies) available for adenosine monophosphate and Diabetic Nephropathies
| Article | Year |
|---|---|
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Neph
Topics: Administration, Oral; Adsorption; AMP-Activated Protein Kinases; Animals; Crystallography, X-Ray; Diabetic Nephropathies; Dogs; Enzyme Activators; High-Throughput Screening Assays; Humans; Indazoles; Indoles; Injections, Intravenous; Macaca fascicularis; Male; Models, Molecular; Protein Conformation; Rats | 2016 |
Development and validation of an LC-MS/MS method for simultaneous determination of remdesivir and its hydrolyzed metabolite and nucleoside, and its application in a pharmacokinetic study of normal and diabetic nephropathy mice.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chromatography, Liquid; COVID-19 Drug Treatment; Diabetes Mellitus; Diabetic Nephropathies; Mice; Mice, Inbred DBA; Nucleosides; Tandem Mass Spectrometry | 2022 |
Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase α (AMPKα) in renal glomerular endothelial cells.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Cell Survival; Cells, Cultured; Diabetic Nephropathies; Glucose; Heterocyclic Compounds, 2-Ring; Humans; Inflammasomes; Kidney Glomerulus; NLR Family, Pyrin Domain-Containing 3 Protein; Pyrans; Signal Transduction | 2021 |
Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats.
Topics: Adenosine; Adenosine Monophosphate; Animals; Biological Availability; Diabetic Nephropathies; Equilibrative Nucleoside Transporter 1; Hydrolysis; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Transforming Growth Factor beta | 2009 |
[Carbohydrate metabolism in placentas of diabetic pregnant women. Note I].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adult; Carbohydrate Metabolism; Diabetic Angiopathies; Diabetic Nephropathies; Female; Fluorides; Glycolysis; Humans; Iodoacetates; Placenta; Pregnancy; Pregnancy in Diabetics; Pyridines; Uridine | 1975 |